Lipid Age Acceleration Raises Cancer Patients' Death Risk 9% Per Year
A new study in Aging and Disease shows lipid age acceleration independently predicts cancer patients' survival, with each extra year raising death risk by 9% (HR=1.09). A lipid clock trained on pancreatic cancer patients accurately predicted healthy people's ages, with sphingolipid SM 41:2 emerging as the most stable protective marker.
2026-09-03 ~ 2026-09-03 · 4 related posts
- Lipid clock trained only on cancer patients accurately predicts age in healthy people — MaxUnfried · 2026-09-03
- Lipid Age Acceleration stays predictive after adjusting for age, BMI, staging — MaxUnfried · 2026-09-03
- Lipid Age Acceleration independently predicts cancer survival, HR=1.09 per year — MaxUnfried · 2026-09-03
- Bootstrap selection finds sphingolipid SM 41:2 the most stable protective feature — MaxUnfried · 2026-09-03